Risks and limits of Longevity Männer

The risks and limits of longevity tests for men primarily stem from weak evidence and marketing-driven claims. The MyBody-X DNA Longevity Test analyzes genetic variants linked to aging pathways, but effect sizes are small and predictive value is low. No randomized controlled trials validate the test's longevity claims. Such tests cannot predict lifespan and serve only as a general guide. Many tested SNPs (e.g., IL-1B rs1143634 or GPX1 rs1050450) have only mechanistic or GWAS associations with inflammation or oxidative stress, without direct human evidence for clinical relevance in men. Results may cause unnecessary anxiety or false reassurance. Lifestyle factors—diet, exercise, sleep, stress management—are far more impactful than genetic predisposition. Additionally, sex-specific research on longevity markers is still limited. Men should not treat these tests as medical diagnoses or personalized anti-aging prescriptions, but at most as supplementary information under medical supervision. The evidence is predominantly marketing-based and insufficient for informed decision-making.